The dispute between Indian-based Meril Life Sciences and Edwards Lifesciences Corporation and Edwards Lifesciences, LLC (collectively Edwards) started almost five years ago in late fall 2019. The case ...
Meril Life Sciences Pvt Ltd. recently launched its next generation transcatheter heart valve (THV), the Myval Octapro THV, which it says allows for better operator control for precise positioning and ...
In a landmark decision (UPC_CFI_15/2023) delivered on November 15, 2024, the Unified Patent Court's Local Division in Munich (UPC, LDM) ruled in favor of Edwards Lifesciences Corporation in a patent ...
The MarketWatch News Department was not involved in the creation of this content. VAPI, India, Nov. 19, 2024 /PRNewswire/ -- Meril, a global leader in cutting-edge cardiovascular and structural heart ...
At one-year, the Myval THV series demonstrated comparable composite clinical efficacy, defined as freedom from all-cause mortality, all stroke, and procedure- or valve-related hospitalization, when ...
Indian medtech company Meril Life Sciences has reportedly filed an antitrust complaint with the European Commission against Edwards Lifesciences (NYSE:EW) related to patents covering Edwards' SAPIEN ...
Data from Meril Life Sciences Pvt Ltd.’s Landmark trial showed that its series of Myval transcatheter heart valves were non-inferior compared with Edwards Lifesciences Corp.’s Sapien BEV and Medtronic ...
Transcatheter Aortic Valve Replacement (Tavr) Market report lists the leading competitors, type, application and provides the insights, strategic industry Analysis of the key factors influencing the ...
U.S. heart valve maker Edwards Lifesciences has been hit with an EU antitrust complaint by Indian rival Meril including for allegedly anti-competitive practices related to patents, a move that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results